Gunshot Injuries Treatment Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027
Gunshot Injuries Treatment Market Report Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
According to an article published by Medscape, pregnancy-related mortality ratio was estimated to be 17.3 deaths per 100,000 pregnant women, with around 11.4% of these deaths caused due by postpartum hemorrhage, in 2013. The initiatives taken by organizations such as the United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and the UK Government to aid research for the development of preventive devices for PPH is a major factor causing expansion of the gunshot injuries treatment market.
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/
Furthermore, the development of the XSTAT-PPH device by Oregon Health & Science Univsersity and RevMedx for the treatment of postpartum hemorrhage (PPH) in low resource settings accelerates growth of the gunshot injuries treatment market.
Surgical priorities for prevention of gunshot management includes hemorrhage control, prevention, and reconstruction of infection, as gunshot has potential to damage affected tissues. The Xstat syringe was the only FDA-approved device for immediate treatment of blood flow.
Browse Research Report: https://www.coherentmarketinsights.com/
Key takeaways of the Gunshot Injuries Treatment Market:
The global gunshot injuries treatment market is expected to exhibit a CAGR of 8.2% over the forecast period, with economies in Asia Pacific, Latin America, Middle East, and Africa focusing on increasing their military spending.
The Xstat is the dominant product segment in the market, as this portable device provides emergency treatment for soldiers in the battlefield
RevMedx, Inc currently is the only player involved in the global gunshot injuries treatment market.
Buy-Now this research report: https://www.coherentmarketinsights.com/